Tang Capital Management as of June 30, 2020
Portfolio Holdings for Tang Capital Management
Tang Capital Management holds 21 positions in its portfolio as reported in the June 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Odonate Therapeutics Ord | 57.9 | $596M | 14M | 42.34 | |
| Biohaven Pharmaceutical Holding | 7.0 | $72M | 981k | 73.11 | |
| Rocket Pharmaceuticals (RCKT) | 6.0 | $62M | 3.0M | 20.93 | |
| Anaptysbio Inc Common (ANAB) | 5.5 | $57M | 2.5M | 22.34 | |
| Heron Therapeutics (HRTX) | 4.1 | $43M | 2.9M | 14.71 | |
| La Jolla Pharmaceuticl Com Par | 3.6 | $37M | 8.7M | 4.26 | |
| Bio Rad Labs Cl A (BIO) | 3.5 | $36M | 80k | 451.49 | |
| United Therapeutics Corporation (UTHR) | 2.4 | $24M | 200k | 121.00 | |
| Relmada Therapeutics (RLMD) | 2.2 | $22M | 500k | 44.75 | |
| Puma Biotechnology (PBYI) | 1.4 | $14M | 1.4M | 10.43 | |
| Sangamo Biosciences (SGMO) | 1.4 | $14M | 1.6M | 8.96 | |
| Avrobio Ord (AVRO) | 1.4 | $14M | 800k | 17.45 | |
| Eagle Pharmaceuticals (EGRX) | 1.2 | $12M | 256k | 47.98 | |
| Coherus Biosciences (CHRS) | 1.0 | $9.8M | 550k | 17.86 | |
| Lifesci Acquisition Corp Unit 03/31/2025 | 0.5 | $5.5M | 500k | 11.00 | |
| Prothena Corp SHS (PRTA) | 0.3 | $2.9M | 274k | 10.46 | |
| Cytomx Therapeutics (CTMX) | 0.2 | $2.5M | 300k | 8.33 | |
| Vanda Pharmaceuticals (VNDA) | 0.2 | $2.2M | 191k | 11.44 | |
| Radius Health Com New | 0.2 | $1.6M | 119k | 13.63 | |
| Nucana Sponsored Adr (NCNA) | 0.1 | $541k | 100k | 5.41 | |
| Tenax Therapeutics Com New | 0.0 | $416k | 460k | 0.90 |
